Published in Vaccine Weekly, August 12th, 2009
"The purpose of this study was to biologically characterize this protein and its immunogenicity compared to that of native pp65....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2009-08-12)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.